Melox

Meloxicam, the active ingredient in Melox, is a non‑steroidal anti‑inflammatory drug presented as an oral dosage form for oral use. It reduces pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis and acute musculoskeletal pain.

GNH USA supplies Melox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melox, an NSAID, is employed to manage inflammatory joint and musculoskeletal disorders.

Osteoarthritis: alleviates joint pain and improves mobility. Rheumatoid arthritis: reduces inflammation and slows disease progression. Acute musculoskeletal pain: provides rapid relief of pain and swelling.

Melox may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dyspepsia or stomach upset. - Nausea and occasional vomiting. - Headache or dizziness. - Peripheral edema. - Mild hypertension.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic enzyme elevation or liver injury. - Acute renal failure or worsening of chronic kidney disease.

Before initiating therapy with Melox, consider the following safety measures.

Assess renal function: adjust use in patients with impaired kidney function. Monitor hepatic enzymes: watch for signs of liver injury. Use the lowest effective dose: limit duration to reduce risk. Avoid in known NSAID hypersensitivity: discontinue if allergic reactions occur. Consider cardiovascular risk: evaluate history of heart disease before use. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Melox can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: elevated lithium levels and toxicity. - High‑dose methotrexate: reduced clearance and toxicity. - ACE inhibitors or ARBs combined with diuretics: potential renal impairment.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of gastrointestinal ulceration. - SSRIs or SNRIs: modest increase in bleeding tendency. - Diuretics: possible electrolyte disturbances. - Oral hypoglycemics: may affect blood glucose control.